Newsroom

News

The Helmholtz Centre for Infection Research (HZI) has appointed PD Dr Fabian Leendertz as founding director of the Helmholtz Institute for One Health (HIOH) in Greifswald on 26 May 2021. At the same time, he accepted his appointment to a W3 professorship for One Health at the University of Greifswald and is expected to become a university professor on 1 August 2021. As another site of the HZI, the HIOH will in future cooperate closely with the University of Greifswald, Greifswald University Hospital and the Friedrich Loeffler Institute. One Health involves interdisciplinary research at the interface of human health, animal health and the environment.

16.06.2021

HIOH

News

How can we apply the knowledge we have gained so far to better overcome the current crisis and prevent another pandemic in future? Helmholtz aims to find answers to these questions with two new, interdisciplinary collaborative projects. In addition to the holistic approach, the focus is also on quickly implementing the results into practice.

20.05.2021

HZI Campus

News

Am I infected with SARS-CoV-2? Is it one of the dangerous variants? Being able to answer these and more questions with a single efficient diagnostic test can be decisive for gauging the spread of disease and selecting the right therapy. In a study published today in the journal "Science", researchers from Würzburg at the Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius Maximilians University (JMU), tackle this challenge with a new CRISPR discovery they translated into a diagnostic platform called LEOPARD.

27.04.2021

HIRI

News

After exposure to a virus through infection or vaccination, the body activates a number of cells and mechanisms that can provide targeted defense against the pathogen. For the global containment of the SARS-CoV-2 pandemic, the question of how long this protection lasts is an important factor. Prof Carlos Guzmán, vaccine researcher at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, summarizes what is known about long-term immunity to SARS-CoV-2 and what difference it makes whether immunity is acquired through vaccination or infection.

08.04.2021

HZI Campus

News

In May 2020, the international consortium iCAIR® started a research project aimed at developing therapeutics against SARS-CoV-2. The Helmholtz Centre for Infection Research (HZI), which joined forces with the consortium's core team last year, is also closely involved in this project. The HZI researchers under the leadership of Prof. Ulrich Kalinke have expanded the iCAIR® outstanding talent pool: they boast a successful track record in antiviral drug research, in particular against human pathogenic RNA viruses, and have compound libraries as well as test models and primary virus isolates. In addition, a team from Fraunhofer ITMP led by Prof. Carsten Claussen and Dr. Ole Pless is on board as a temporary project partner. The iCAIR® research team already can report promising results, which were presented by iCAIR® coordinator Prof. Armin Braun and others at Fraunhofer ITEM's virtual workshop "Models of Lung Disease" in January.

08.04.2021

TWINCORE

Rasterelektronenmikroskopische Aufnahme von Mycobacterium tuberculosis

News

Every year, about 10 million people become infected with tuberculosis and 1.4 million die from it. This makes tuberculosis not only one of the most widespread infectious diseases, but also the deadliest. Similar to malaria or HIV, the prevalence of tuberculosis is strongly dependent on social factors; it is considered a classic disease of the poor. In addition to a lack of medical care, other problems hinder the containment of tuberculosis, such as antibiotic resistance and undesirable drug-drug interactions.

24.03.2021

Back to the first page
...
47
48
49
50
...
137

HZI in the media

... erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in Höhe ...

25.11.2025

Bionity.COM

led by Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) has now discovered clear molecular signatures for

24.11.2025

Medical Xpress

Medizinischen Hochschule Hannover (MHH) und dem Helmholtz-Zentrum für Infektionsforschung (HZI), hat nun eindeutige molekulare Signaturen ...

24.11.2025

DeutschesGesundheitsPortal

Braunschweig. Das Helmholtz-Zentrum für Infektionsforschung (HZI) bringt anlässlich seines 60. Jubiläums seine Forschung vom 3. ...

22.11.2025

Regional Heute

Universität Hannover (LUH), dem Helmholtz Zentrum für Infektionsforschung (HZI) in Braunschweig, der Technischen Universität Braunschweig ...

21.11.2025

Medizinische Hochschule Hannover

... 38100 Braunschweig Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung ( ...

20.11.2025

Bochumer-Zeitung

Dr. Dunja Bruder ist Forschungsgruppenleiterin am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und zugleich Professorin für

20.11.2025

Bilanz

... Wissenschaftler und Wissenschaftlerinnen des Helmholtz-Zentrums für Infektionsforschung (HZI) und der Medizinischen Hochschule ...

19.11.2025

Rheinische Post

... Forschungsschwerpunkt „Neue Antiinfektiva“ des Helmholtz-Zentrums für Infektionsforschung (HZI) entwickeln fast 20 Forschungsgruppen neue ...

18.11.2025

Regional Heute

... , Stellvertretende Teamleiterin der Klinischen Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI), Braunschweig.

17.11.2025

Biermann Medizin

... und individueller Darmflora ab.

Forscher am Helmholtz-Zentrum für Infektionsforschung arbeiten bereits an der nächsten Generation ...

14.11.2025

Ad Hoc News

Klett-Tammen, Abteilung Epidemiologie (EPID), Helmholtz-Zentrum für Infektionsforschung (

HZI

), Braunschweig. Grundsätzlich sei auch die ...

13.11.2025

Deutsches Ärzteblatt

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.